Information about Mounjaro (Tirzepatide) for weight loss.
Information about Mounjaro (Tirzepatide) for weight loss.
Mounjaro is the brand name for Tirzepatide. It is a medication used together with diet, exercise, and support to help with weight loss for people living with obesity.
It is an injection which you give to yourself once a week and works by suppressing the appetite, making you feel fuller for longer.
Mounjaro is being approved for NHS prescribing. However, initially it will only be available through specialist pathways, not directly from your GP. These pathways are being finalised and will follow national guidelines.
Due to the high cost of the medication and phased NHS roll out, not everyone will qualify for treatment immediately.
For more support with healthy eating and weight loss see:
It will be available for people who have a BMI of over 35 and a weight-related health problem, an estimated 3.4 million people will be eligible.
It will not be available until spring 2025 and will initially be offered to patients with the most significant health risks.
We will put out further information when we are able to refer patients into the service.